This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Orthobiologics Market

Market Insights on Orthobiologics covering sales outlook, demand forecast & up-to-date key trends

Orthobiologics Market By Product Type (Bone Growth Stimulators, Viscosupplements, Bone Graft Substitute), End User (Hospitals, Ambulatory Surgical Centres, Orthopaedics Clinics) & Region - Forecast 2021 - 2027

Orthobiologics Market Overview

[282 Pages Report] The orthobiologics market is valued at US$ 5.3 Billion in 2021. The market is likely to grow at a CAGR of 3.5% through 2027, reaching US$ 6.5 Billion.

Attribute

Details

Estimated Market Size of Orthobiologics Market in 2021

US$ 5.3 Bn

Projected Market Size of Orthobiologics Market in 2027

US$ 6.5 Bn

CAGR during 2021-2027

3.5%

North America is the lucrative region of orthobiologics market with an expected value of US$ 3 Bn whereas (APEJ) is projected to rise at a higher CAGR of 4.4% through 2027.

Hospitals are the lucrative sector of the market. Orthopaedic clinics are also expected to register a CAGR of 3.6% through 2027.

Through 2027, the largest segment, bone graft stimulators are expected to attain a market size of over US$ 3 Billion.

Increasing geriatric population offers surplus opportunities for the manufactures of orthobiologics. The major root of amputations are diseases related to ageing as osteoarthritis, musculoskeletal diseases, spine deformity, etc. Increase incidence of accidents owing to increasing urbanization is also a major factor expected to create numerous opportunities for orthobiologics manufacturers. Elevating surgical procedures also presents growth opportunities for the market.

The increased incidences of trauma cases, lifestyle related diseases and other chronic disorders have led to rise in number of orthopaedic surgeries at a global level. This growing trend is anticipated to increase the sales of orthobiologics products in present and forthcoming years.

Emergence of online sales channel and government initiatives bot are contributing to the growth of the market. Manufacturers are focussed on creating sales directly through their company’s website to target more customers and without the interference of third-party distributors. This enables the manufacturers to eliminate the variation in product pricing owing to the involvement of third-party suppliers.

Customize this Report

Let us know your requirement to get
100% FREE customization

Bone graft substitutes continue to exert a hold on the global market

Bone graft substitute segment in the product type category is expected to dominate the global market in the years to follow. This segment was a lucrative one since 2012. During the 2012-2016 timeline, bone graft substitute segment reflected high growth opportunities and led the global market.

Orthobiologics Market Download Report Brochure

This trend is observed in the current market scenario and is expected to continue over the period of assessment. In 2017, bone graft substitute segment registered a value of US$ US$ 2521.6 Mn and is according to the growth trend exhibited by this segment, it is estimated to reach a market valuation of above US$ 3 Bn by the end of 2027. During the forecast period of 2017-2027, it is poised to reflect a CAGR of 3.0%.

Xenografts to show high potential for growth adding to the domination of bone graft substitutes

Bone graft substitute segment is further analysed and divided into allograft, xenograft, synthetic and bone morphogenetic protein sub segments. Of these, xenograft sub segment is expected to run at the highest pace to register a meteoric CAGR of 10.0% throughout the period of forecast. This segment is the second largest in terms of market value. Allograft and synthetic sub segments have a large yet almost equal contribution to the revenue of the parent segment.

The allograft sub segment is estimated to reach a valuation of US$ 937.5 Mn leading other sub segments. However, the synthetic sub category is poised to grow at a relatively higher rate than allografts in the coming years.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Market segmentation

The global orthobiologics market is segmented in detail so as to cover every aspect of the market and present a complete market intelligence in front of the reader.

By Product Type

  • Bone Growth Stimulators (BGS)
    • Non-Invasive Electrical BGS
    • Invasive Electrical BGS
    • Ultrasound BGS
  • Viscosupplements
    • Single Injection Viscosupplements
    • Three Injection Viscosupplements
    • Five Injection Viscosupplements
  • Bone Graft Substitute
    • Allografts
    • Synthetics
    • Xenografts
    • Bone Morphogenetic Protein

By End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Orthopaedics Clinics

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan (APEJ)
  • Japan
  • Middle East and Africa (MEA)
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Frequently Asked Questions

The orthobiologics market is valued at US$ 5.3 Billion in 2021. The market is likely to grow at a CAGR of 3.5% through 2027, reaching US$ 6.5 Billion.

Some of the leading companies are Zimmer Biomet Holdings, Orthofix International N.V., Anika Therapeutics, Inc., DePuy Synthes (Johnson & Johnson)

Table of Content

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3. Orthobiologics Market Viewpoint

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Regulatory scenario

3.4. Porter’s Five Force Analysis

3.5. PESTLE Analysis

4. North America Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) By Country, 2012-2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016

4.5.1. Bone Growth Stimulators

4.5.1.1. Non-Invasive Electrical BGS

4.5.1.2. Invasive Electrical BGS

4.5.1.3. Ultrasound BGS

4.5.2. VIscosupplements

4.5.2.1. One Injection VIscosupplements

4.5.2.2. Three Injection VIscosupplements

4.5.2.3. Five Injection VIscosupplements

4.5.3. Bone Graft Substitutes

4.5.3.1. Allografts

4.5.3.2. Synthetics

4.5.3.3. Xenografts

4.5.3.4. Bone Morphogenetic Protein

4.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

4.6.1. Bone Growth Stimulators

4.6.1.1. Non-Invasive Electrical BGS

4.6.1.2. Invasive Electrical BGS

4.6.1.3. Ultrasound BGS

4.6.2. VIscosupplements

4.6.2.1. One Injection VIscosupplements

4.6.2.2. Three Injection VIscosupplements

4.6.2.3. Five Injection VIscosupplements

4.6.3. Bone Graft Substitutes

4.6.3.1. Allografts

4.6.3.2. Synthetics

4.6.3.3. Xenografts

4.6.3.4. Bone Morphogenetic Protein

4.7. Historical Market Size (US$ Mn) By End User, 2012-2016

4.7.1. Hospitals

4.7.2. Ambulatory Surgical Centers

4.7.3. Orthopedic Clinics 

4.8. Market Size (US$ Mn) Forecast By End User, 2017-2027

4.8.1. Hospitals

4.8.2. Ambulatory Surgical Centers

4.8.3. Orthopedic Clinics 

4.9. Drivers and Restraints: Impact Analysis

4.10. Market Attractiveness Analysis

4.10.1. By Country

4.10.2. By Product Type

4.10.3. By End User 

4.11. Key Representative Market Participants

4.12. Key Participants Market Presence (Intensity Map)

5. Latin America Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) By Country, 2012-2016

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Argentina

5.3.4. Rest of Latin America

5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

5.4.1. Brazil

5.4.2. Mexico

5.4.3. Argentina

5.4.4. Rest of Latin America

5.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016

5.5.1. Bone Growth Stimulators

5.5.1.1. Non-Invasive Electrical BGS

5.5.1.2. Invasive Electrical BGS

5.5.1.3. Ultrasound BGS

5.5.2. VIscosupplements

5.5.2.1. One Injection VIscosupplements

5.5.2.2. Three Injection VIscosupplements

5.5.2.3. Five Injection VIscosupplements

5.5.3. Bone Graft Substitutes

5.5.3.1. Allografts

5.5.3.2. Synthetics

5.5.3.3. Xenografts

5.5.3.4. Bone Morphogenetic Protein

5.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

5.6.1. Bone Growth Stimulators

5.6.1.1. Non-Invasive Electrical BGS

5.6.1.2. Invasive Electrical BGS

5.6.1.3. Ultrasound BGS

5.6.2. VIscosupplements

5.6.2.1. One Injection VIscosupplements

5.6.2.2. Three Injection VIscosupplements

5.6.2.3. Five Injection VIscosupplements

5.6.3. Bone Graft Substitutes

5.6.3.1. Allografts

5.6.3.2. Synthetics

5.6.3.3. Xenografts

5.6.3.4. Bone Morphogenetic Protein

5.7. Historical Market Size (US$ Mn) By End User, 2012-2016

5.7.1. Hospitals

5.7.2. Ambulatory Surgical Centers

5.7.3. Orthopedic Clinics 

5.8. Market Size (US$ Mn) Forecast By End User, 2017-2027

5.8.1. Hospitals

5.8.2. Ambulatory Surgical Centers

5.8.3. Orthopedic Clinics 

5.9. Drivers and Restraints: Impact Analysis

5.10. Market Attractiveness Analysis

5.10.1. By Country

5.10.2. By Product Type

5.10.3. By End User

5.11. Key Representative Market Participants

5.12. Key Participants Market Presence (Intensity Map)

6. Western Europe Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) By Country, 2012-2016

6.3.1. Germany

6.3.2. United Kingdom

6.3.3. France

6.3.4. Italy

6.3.5. Spain

6.3.6. Benelux

6.3.7. Nordic Region

6.3.8. Rest of Western Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

6.4.1. Germany

6.4.2. United Kingdom

6.4.3. France

6.4.4. Italy

6.4.5. Spain

6.4.6. Benelux

6.4.7. Nordic Region

6.4.8. Rest of Western Europe

6.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016

6.5.1. Bone Growth Stimulators

6.5.1.1. Non-Invasive Electrical BGS

6.5.1.2. Invasive Electrical BGS

6.5.1.3. Ultrasound BGS

6.5.2. VIscosupplements

6.5.2.1. One Injection VIscosupplements

6.5.2.2. Three Injection VIscosupplements

6.5.2.3. Five Injection VIscosupplements

6.5.3. Bone Graft Substitutes

6.5.3.1. Allografts

6.5.3.2. Synthetics

6.5.3.3. Xenografts

6.5.3.4. Bone Morphogenetic Protein

6.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

6.6.1. Bone Growth Stimulators

6.6.1.1. Non-Invasive Electrical BGS

6.6.1.2. Invasive Electrical BGS

6.6.1.3. Ultrasound BGS

6.6.2. VIscosupplements

6.6.2.1. One Injection VIscosupplements

6.6.2.2. Three Injection VIscosupplements

6.6.2.3. Five Injection VIscosupplements

6.6.3. Bone Graft Substitutes

6.6.3.1. Allografts

6.6.3.2. Synthetics

6.6.3.3. Xenografts

6.6.3.4. Bone Morphogenetic Protein

6.7. Historical Market Size (US$ Mn) By End User, 2012-2016

6.7.1. Hospitals

6.7.2. Ambulatory Surgical Centers

6.7.3. Orthopedic Clinics 

6.8. Market Size (US$ Mn) Forecast By End User, 2017-2027

6.8.1. Hospitals

6.8.2. Ambulatory Surgical Centers

6.8.3. Orthopedic Clinics 

6.9. Drivers and Restraints: Impact Analysis

6.10. Market Attractiveness Analysis

6.10.1. By Country

6.10.2. By Product Type

6.10.3. By End User

6.11. Key Representative Market Participants

6.12. Key Participants Market Presence (Intensity Map)

7. Eastern Europe Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Trends

7.3. Historical Market Size (US$ Mn) By Country, 2012-2016

7.3.1. Russia

7.3.2. Poland

7.3.3. Rest of Eastern Europe

7.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

7.4.1. Russia

7.4.2. Poland

7.4.3. Rest of Eastern Europe

7.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016

7.5.1. Bone Growth Stimulators

7.5.1.1. Non-Invasive Electrical BGS

7.5.1.2. Invasive Electrical BGS

7.5.1.3. Ultrasound BGS

7.5.2. VIscosupplements

7.5.2.1. One Injection VIscosupplements

7.5.2.2. Three Injection VIscosupplements

7.5.2.3. Five Injection VIscosupplements

7.5.3. Bone Graft Substitutes

7.5.3.1. Allografts

7.5.3.2. Synthetics

7.5.3.3. Xenografts

7.5.3.4. Bone Morphogenetic Protein

7.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

7.6.1. Bone Growth Stimulators

7.6.1.1. Non-Invasive Electrical BGS

7.6.1.2. Invasive Electrical BGS

7.6.1.3. Ultrasound BGS

7.6.2. VIscosupplements

7.6.2.1. One Injection VIscosupplements

7.6.2.2. Three Injection VIscosupplements

7.6.2.3. Five Injection VIscosupplements

7.6.3. Bone Graft Substitutes

7.6.3.1. Allografts

7.6.3.2. Synthetics

7.6.3.3. Xenografts

7.6.3.4. Bone Morphogenetic Protein

7.7. Historical Market Size (US$ Mn) By End User, 2012-2016

7.7.1. Hospitals

7.7.2. Ambulatory Surgical Centers

7.7.3. Orthopedic Clinics 

7.8. Market Size (US$ Mn) Forecast By End User, 2017-2027

7.8.1. Hospitals

7.8.2. Ambulatory Surgical Centers

7.8.3. Orthopedic Clinics 

7.9. Drivers and Restraints: Impact Analysis

7.10. Market Attractiveness Analysis

7.10.1. By Country

7.10.2. By Product Type

7.10.3. By End User

7.11. Key Representative Market Participants

7.12. Key Participants Market Presence (Intensity Map)

8. Asia Pacific excluding Japan Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Historical Market Size (US$ Mn) By Country, 2012-2016

8.3.1. China

8.3.2. India

8.3.3. Australia and New Zealand

8.3.4. ASEAN

8.3.5. Rest of APEJ

8.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

8.4.1. China

8.4.2. India

8.4.3. Australia and New Zealand

8.4.4. ASEAN

8.4.5. Rest of APEJ

8.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016

8.5.1. Bone Growth Stimulators

8.5.1.1. Non-Invasive Electrical BGS

8.5.1.2. Invasive Electrical BGS

8.5.1.3. Ultrasound BGS

8.5.2. VIscosupplements

8.5.2.1. One Injection VIscosupplements

8.5.2.2. Three Injection VIscosupplements

8.5.2.3. Five Injection VIscosupplements

8.5.3. Bone Graft Substitutes

8.5.3.1. Allografts

8.5.3.2. Synthetics

8.5.3.3. Xenografts

8.5.3.4. Bone Morphogenetic Protein

8.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

8.6.1. Bone Growth Stimulators

8.6.1.1. Non-Invasive Electrical BGS

8.6.1.2. Invasive Electrical BGS

8.6.1.3. Ultrasound BGS

8.6.2. VIscosupplements

8.6.2.1. One Injection VIscosupplements

8.6.2.2. Three Injection VIscosupplements

8.6.2.3. Five Injection VIscosupplements

8.6.3. Bone Graft Substitutes

8.6.3.1. Allografts

8.6.3.2. Synthetics

8.6.3.3. Xenografts

8.6.3.4. Bone Morphogenetic Protein

8.7. Historical Market Size (US$ Mn) By End User, 2012-2016

8.7.1. Hospitals

8.7.2. Ambulatory Surgical Centers

8.7.3. Orthopedic Clinics 

8.8. Market Size (US$ Mn) Forecast By End User, 2017-2027

8.8.1. Hospitals

8.8.2. Ambulatory Surgical Centers

8.8.3. Orthopedic Clinics 

8.9. Drivers and Restraints: Impact Analysis

8.10. Market Attractiveness Analysis

8.10.1. By Country

8.10.2. By Product Type

8.10.3. By End User

8.11. Key Representative Market Participants

8.12. Key Participants Market Presence (Intensity Map)

9. Japan Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Regional Market Dynamics

9.2.1. Drivers

9.2.2. Restraints

9.2.3. Trends

9.3. Historical Market Size (US$ Mn) By Product Type, 2012-2016

9.3.1. Bone Growth Stimulators

9.3.1.1. Non-Invasive Electrical BGS

9.3.1.2. Invasive Electrical BGS

9.3.1.3. Ultrasound BGS

9.3.2. VIscosupplements

9.3.2.1. One Injection VIscosupplements

9.3.2.2. Three Injection VIscosupplements

9.3.2.3. Five Injection VIscosupplements

9.3.3. Bone Graft Substitutes

9.3.3.1. Allografts

9.3.3.2. Synthetics

9.3.3.3. Xenografts

9.3.3.4. Bone Morphogenetic Protein

9.4. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

9.4.1. Bone Growth Stimulators

9.4.1.1. Non-Invasive Electrical BGS

9.4.1.2. Invasive Electrical BGS

9.4.1.3. Ultrasound BGS

9.4.2. VIscosupplements

9.4.2.1. One Injection VIscosupplements

9.4.2.2. Three Injection VIscosupplements

9.4.2.3. Five Injection VIscosupplements

9.4.3. Bone Graft Substitutes

9.4.3.1. Allografts

9.4.3.2. Synthetics

9.4.3.3. Xenografts

9.4.3.4. Bone Morphogenetic Protein

9.5. Historical Market Size (US$ Mn) By End User, 2012-2016

9.5.1. Hospitals

9.5.2. Ambulatory Surgical Centers

9.5.3. Orthopedic Clinics 

9.6. Market Size (US$ Mn) Forecast By End User, 2017-2027

9.6.1. Hospitals

9.6.2. Ambulatory Surgical Centers

9.6.3. Orthopedic Clinics 

9.7. Drivers and Restraints: Impact Analysis

9.8. Market Attractiveness Analysis

9.8.1. By Product Type

9.8.2. By End User

9.9. Key Representative Market Participants

9.10. Key Participants Market Presence (Intensity Map)

10. Middle East & Africa Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Regional Market Dynamics

10.2.1. Drivers

10.2.2. Restraints

10.2.3. Trends

10.3. Historical Market Size (US$ Mn) By Country, 2012-2016

10.3.1. GCC Countries

10.3.2. South Africa

10.3.3. Rest of MEA

10.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

10.4.1. GCC Countries

10.4.2. South Africa

10.4.3. Rest of MEA

10.5. Historical Market Size (US$ Mn) By Product Type, 2012-2016

10.5.1. Bone Growth Stimulators

10.5.1.1. Non-Invasive Electrical BGS

10.5.1.2. Invasive Electrical BGS

10.5.1.3. Ultrasound BGS

10.5.2. VIscosupplements

10.5.2.1. One Injection VIscosupplements

10.5.2.2. Three Injection VIscosupplements

10.5.2.3. Five Injection VIscosupplements

10.5.3. Bone Graft Substitutes

10.5.3.1. Allografts

10.5.3.2. Synthetics

10.5.3.3. Xenografts

10.5.3.4. Bone Morphogenetic Protein

10.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

10.6.1. Bone Growth Stimulators

10.6.1.1. Non-Invasive Electrical BGS

10.6.1.2. Invasive Electrical BGS

10.6.1.3. Ultrasound BGS

10.6.2. VIscosupplements

10.6.2.1. One Injection VIscosupplements

10.6.2.2. Three Injection VIscosupplements

10.6.2.3. Five Injection VIscosupplements

10.6.3. Bone Graft Substitutes

10.6.3.1. Allografts

10.6.3.2. Synthetics

10.6.3.3. Xenografts

10.6.3.4. Bone Morphogenetic Protein

10.7. Historical Market Size (US$ Mn) By End User, 2012-2016

10.7.1. Hospitals

10.7.2. Ambulatory Surgical Centers

10.7.3. Orthopedic Clinics 

10.8. Market Size (US$ Mn) Forecast By End User, 2017-2027

10.8.1. Hospitals

10.8.2. Ambulatory Surgical Centers

10.8.3. Orthopedic Clinics 

10.9. Drivers and Restraints: Impact Analysis

10.10. Market Attractiveness Analysis

10.10.1. By Country

10.10.2. By Product Type

10.10.3. By End User

10.11. Key Representative Market Participants

10.12. Key Participants Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

13.1. Market Structure

13.2. Market Share Analysis 

13.3. Competition Dashboard

13.4. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

13.4.1. Medtronic plc

13.4.2. NuVasive, Inc.

13.4.3. Stryker Corporation

13.4.4. Zimmer Biomet Holdings

13.4.5. Orthofix International N.V.

13.4.6. Anika Therapeutics, Inc.

13.4.7. DePuy Synthes (Johnson & Johnson)

13.4.8. Bioventus

13.4.9. Arthrex, Inc.

13.4.10. SeaSpine Holdings Corporation

13.4.11. Sanofi-Aventis (Sanofi SA)

13.4.12. Djo Global, Inc.

13.4.13. Seikagaku Corporation

13.4.14. RTI Surgical, Inc.

13.4.15. Heraeus Holding GmbH  

13.4.16. Fidia Pharma USA Inc.   

13.4.17. TRB Chemedica International SA

13.4.18. Allosource 

13.4.19. Musculoskeletal Transplant Foundation, Inc.

13.4.20. Ito Co., Ltd.

14. Global Orthobiologics Market Analysis and Forecast, By Region

14.1. Introduction

14.2. Historical Market Size (US$ Mn) By Region, 2012-2016

14.2.1. North America

14.2.2. Latin America

14.2.3. Western Europe

14.2.4. Eastern Europe

14.2.5. Asia Pacific Excl. Japan (APEJ)

14.2.6. Japan

14.2.7. Middle East and Africa (MEA)

14.3. Market Size (US$ Mn) Forecast By Region, 2017-2027

14.3.1. North America

14.3.2. Latin America

14.3.3. Western Europe

14.3.4. Eastern Europe

14.3.5. Asia Pacific Excl. Japan (APEJ)

14.3.6. Japan

14.3.7. Middle East and Africa (MEA)

14.4. Market Attractiveness Analysis By Region

15. Global Orthobiologics Market Analysis and Forecast, By Product Type

15.1. Introduction

15.2. Historical Market Size (US$ Mn) By Product Type, 2012-2016

15.2.1. Bone Growth Stimulators

15.2.1.1. Non-Invasive Electrical BGS

15.2.1.2. Invasive Electrical BGS

15.2.1.3. Ultrasound BGS

15.2.2. VIscosupplements

15.2.2.1. One Injection VIscosupplements

15.2.2.2. Three Injection VIscosupplements

15.2.2.3. Five Injection VIscosupplements

15.2.3. Bone Graft Substitutes

15.2.3.1. Allografts

15.2.3.2. Synthetics

15.2.3.3. Xenografts

15.2.3.4. Bone Morphogenetic Protein

15.3. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

15.3.1. Bone Growth Stimulators

15.3.1.1. Non-Invasive Electrical BGS

15.3.1.2. Invasive Electrical BGS

15.3.1.3. Ultrasound BGS

15.3.2. VIscosupplements

15.3.2.1. One Injection VIscosupplements

15.3.2.2. Three Injection VIscosupplements

15.3.2.3. Five Injection VIscosupplements

15.3.3. Bone Graft Substitutes

15.3.3.1. Allografts

15.3.3.2. Synthetics

15.3.3.3. Xenografts

15.3.3.4. Bone Morphogenetic Protein

15.4. Market Attractiveness Analysis By Product Type

16. Global Orthobiologics Market Analysis and Forecast, By End User

16.1. Introduction

16.2. Historical Market Size (US$ Mn) By End User, 2012-2016

16.2.1. Hospital 

16.2.2. Ambulatory Surgical Centers

16.2.3. Orthopedic Clinics

16.3. Market Size (US$ Mn) Forecast By End User, 2017-2027

16.3.1. Hospital Pharmacies

16.3.2. Retail Pharmacies

16.3.3. Online Pharmacies 

16.4. Market Attractiveness Analysis By End User

17. Global Orthobiologics Market Analysis 2012–2016 and Forecast 2017–2027

17.1. Market Size and Y-o-Y Growth

17.2. Absolute $ Opportunity

18. Assumptions and Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: North America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 02: North America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 03: North America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 04: Latin America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 05: Latin America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 06: Latin America Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 07: Western Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 08: Western Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 09: Western Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 10: Eastern Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 11: Eastern Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 12: Eastern Europe Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 13: APEJ Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 14: APEJ Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 15: APEJ Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 16: Japan Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 17: Japan Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 18: MEA Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 19: MEA Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 20: MEA Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Table 21: Global Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Region

Table 22: Global Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 23: Global Orthobiologics Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: North America Orthobiologics Market Value Share By Product Type (2017)

Figure 02: North America Orthobiologics Market Value Share By End User (2017)

Figure 03: North America Orthobiologics Market Value Share By Country (2017)

Figure 04: North America Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 05: North America Orthobiologics Market Size (US$ Mn)        & Y-o-Y Growth (%), 2017-2027

Figure 06: U.S. Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 08: Canada Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 07: U.S. Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 09: Canada Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 10: North America Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016

Figure 11: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027

Figure 12: North America Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016

Figure 13: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027

Figure 14: North America Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016

Figure 15: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027

Figure 16: North America Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016

Figure 17: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027

Figure 18: North America Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016

Figure 19: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027

Figure 20: North America Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016

Figure 21: North America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027

Figure 22: North America Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 23: North America Orthobiologics Market Attractiveness Analysis By End User, 2017–2027 

Figure 24: North America Orthobiologics Market Attractiveness Analysis By Country, 2017–2027 

Figure 25: Latin America Orthobiologics Market Value Share By Product Type (2017)

Figure 26: Latin America Orthobiologics Market Value Share By End User (2017)

Figure 27: Latin America Orthobiologics Market Value Share By Country (2017)

Figure 28: Latin America Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 29: Latin America Orthobiologics Market Size (US$ Mn)        & Y-o-Y Growth (%), 2017-2027

Figure 30: Brazil  Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 31: Brazil Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 32: Mexico Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 33: Mexico Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 34: Argentina Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 35: Argentina Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 36: Rest of Latin America Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 37: Rest of Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 38: Latin America Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016

Figure 39: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027

Figure 40: Latin America Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016

Figure 41: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027

Figure 42: Latin America Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016

Figure 43: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027

Figure 44: Latin America Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016

Figure 45: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027

Figure 46: Latin America Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016

Figure 47: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027

Figure 48: Latin America Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016

Figure 49: Latin America Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027

Figure 50: Latin America Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 51: Latin America Orthobiologics Market Attractiveness Analysis By End User, 2017–2027 

Figure 52: North America Orthobiologics Market Attractiveness Analysis By Country, 2017–2027 

Figure 53: Western Europe Orthobiologics Market Value Share By Product Type (2017)

Figure 54: Western Europe Orthobiologics Market Value Share By End User (2017)

Figure 55: Western Europe Orthobiologics Market Value Share By Country (2017)

Figure 56: Western Europe Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 57: Western Europe Orthobiologics Market Size (US$ Mn)        & Y-o-Y Growth (%), 2017-2027

Figure 58: UK Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 59: UK Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 60: Germany Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 61: Germany Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 62: France Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 63: France Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 64: Italy Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 65: Italy Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 66: Spain Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 67: Spain Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 68: Nordic Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 69: Nordic Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 70: BENELUX Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 71: BENELUX Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 72: Rest of Western Europe Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 73: Rest of Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 74: Western Europe Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016

Figure 75: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027

Figure 76: Western Europe Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016

Figure 77: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027

Figure 78: Western Europe Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016

Figure 79: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027

Figure 80: Western Europe Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016

Figure 81: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027

Figure 82: Western Europe Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016

Figure 83: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027

Figure 84: Western Europe Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016

Figure 85: Western Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027

Figure 86: Western Europe Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 87: Western Europe Orthobiologics Market Attractiveness Analysis By End User, 2017–2027 

Figure 88: Western Europe Orthobiologics Market Attractiveness Analysis By Country, 2017–2027 

Figure 89: Eastern Europe Orthobiologics Market Value Share By Product Type (2017)

Figure 90: Eastern Europe Orthobiologics Market Value Share By End User (2017)

Figure 91: Eastern Europe Orthobiologics Market Value Share By Country (2017)

Figure 92: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 93: Eastern Europe Orthobiologics Market Size (US$ Mn)        & Y-o-Y Growth (%), 2017-2027

Figure 94: Russia Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 95: Russia Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 96: Poland Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 97: Poland Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 98: Rest of Eastern Europe Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 99: Rest of Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 100: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016

Figure 101: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027

Figure 102: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016

Figure 103: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027

Figure 104: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016

Figure 105: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027

Figure 106: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016

Figure 107: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027

Figure 108: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016

Figure 109: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027

Figure 110: Eastern Europe Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016

Figure 111: Eastern Europe Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027

Figure 112: Eastern Europe Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 113: Eastern Europe Orthobiologics Market Attractiveness Analysis By End User, 2017–2027 

Figure 114: Eastern Europe Orthobiologics Market Attractiveness Analysis By Country, 2017–2027 

Figure 115: APEJ Orthobiologics Market Value Share By Product Type (2017)

Figure 116: APEJ Orthobiologics Market Value Share By End User (2017)

Figure 117: APEJ Orthobiologics Market Value Share By Country (2017)

Figure 118: APEJ Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 119: APEJ Orthobiologics Market Size (US$ Mn)        & Y-o-Y Growth (%), 2017-2027

Figure 120: China Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 121: China Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 122: India Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 123: India Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 124: ANZ Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 125: ANZ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 126: ASEAN Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 127: ASEAN Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 128: Rest of APEJ Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 129: Rest of APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 130: APEJ Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016

Figure 131: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027

Figure 132: APEJ Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016

Figure 133: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027

Figure 134: APEJ Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016

Figure 135: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027

Figure 136: APEJ Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016

Figure 137: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027

Figure 138: APEJ Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016

Figure 139: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027

Figure 140: APEJ Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016

Figure 141: APEJ Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027

Figure 142: APEJ Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 143: APEJ Orthobiologics Market Attractiveness Analysis By End User, 2017–2027 

Figure 144: APEJ Orthobiologics Market Attractiveness Analysis By Country, 2017–2027 

Figure 145: Japan Orthobiologics Market Value Share By Product Type (2017)

Figure 146: Japan Orthobiologics Market Value Share By End User (2017)

Figure 147: Japan Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 148: Japan Orthobiologics Market Size (US$ Mn)        & Y-o-Y Growth (%), 2017-2027

Figure 149: Japan Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016

Figure 150: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027

Figure 151: Japan Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016

Figure 152: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027

Figure 153: Japan Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016

Figure 154: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027

Figure 155: Japan Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016

Figure 156: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027

Figure 157: Japan Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016

Figure 158: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027

Figure 159: Japan Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016

Figure 160: Japan Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027

Figure 161: Japan Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 162: Japan Orthobiologics Market Attractiveness Analysis By End User, 2017–2027 

Figure 163: MEA Orthobiologics Market Value Share By Product Type (2017)

Figure 164: MEA Orthobiologics Market Value Share By End User (2017)

Figure 165: MEA Orthobiologics Market Value Share By Country (2017)

Figure 166: MEA Orthobiologics Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 167: MEA Orthobiologics Market Size (US$ Mn)        & Y-o-Y Growth (%), 2017-2027

Figure 168: South Africa Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 169: South Africa Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 170: GCC Countries Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 171: GCC Countries Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 172: Rest of MEA Orthobiologics Historical Market Size (US$ Mn), 2012–2016

Figure 173: Rest of MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 174: MEA Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulator, 2012–2016

Figure 175: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulator, 2017–2027

Figure 176: MEA Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016

Figure 177: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027

Figure 178: MEA Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016

Figure 179: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Substitute, 2017–2027

Figure 180: MEA Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016

Figure 181: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027

Figure 182: MEA Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016

Figure 183: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027

Figure 184: MEA Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016

Figure 185: MEA Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027

Figure 186: MEA Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 187: MEA Orthobiologics Market Attractiveness Analysis By End User, 2017–2027 

Figure 188: MEA Orthobiologics Market Attractiveness Analysis By Country, 2017–2027 

Figure 189: Global Orthobiologics Market Y-o-Y Growth (%) 2017–2027, By Region

Figure 190: Global Orthobiologics Market Attractiveness Analysis By Region, 2017–2027 

Figure 191: Global Orthobiologics Market Y-o-Y Growth (%) 2017–2027, By Product Type 

Figure 192: Global Orthobiologics Historical Market Size (US$ Mn) By Bone Growth Stimulation, 2012–2016

Figure 193: Global Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Growth Stimulation, 2017–2027

Figure 194: Global Orthobiologics Historical Market Size (US$ Mn) By Viscosupplement, 2012–2016

Figure 195: Global Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Viscosupplement, 2017–2027

Figure 196: Global Orthobiologics Historical Market Size (US$ Mn) By Bone Graft Substitute, 2012–2016

Figure 197: Global Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Bone Graft Subsitute, 2017–2027

Figure 198: Global Orthobiologics Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 199: Global Orthobiologics Market Y-o-Y Growth (%) 2017–2027, By End User 

Figure 200: Global Orthobiologics Historical Market Size (US$ Mn) By Hospitals, 2012–2016

Figure 201: Global Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2017–2027

Figure 202: Global Orthobiologics Historical Market Size (US$ Mn) By Ambulatory Surgical Centers, 2012–2016

Figure 203: Global Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2017–2027

Figure 204: Global Orthobiologics Historical Market Size (US$ Mn) By Orthopedic Clinics, 2012–2016

Figure 205: Global Orthobiologics Market Size (US$ Mn) & Y-o-Y Growth (%) By Orthopedic Clinics, 2017–2027

Figure 206: Global Orthobiologics Market Attractiveness Analysis By End User, 2017–2027 

Figure 207: Global Orthobiologics Market Value Analysis and Forecast, 2016–2027 (US$ Mn)

Figure 208: Global Orthobiologics Market Value (US$ Mn), 2012–2016

Figure 209: Global Orthobiologics Market Absolute $ Opportunity (US$ Mn), 2016–2027

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Bacteriophage Market

Published : April 2022

Healthcare

Autoclaves Market

Published : December 2020

Healthcare

Stethoscope Market

Published : October 2020

Healthcare

Vascular prostheses market

Published : September 2020

Google translate

Orthobiologics Market